Investment
Features
FeesSafety
Academy
More
Pluang+

Mirion Technologies shows strong growth and profits in nuclear tech amid sector maturation.

Market News
23 Sep 2026
Seeking Alpha
View Source
Bullish
Mirion Technologies shows strong growth and profits in nuclear tech amid sector maturation.

Mirion Technologies, a US-based company involved in nuclear technology and nuclear medicine, is experiencing revenue growth and strong profits with a solid adjusted EBITDA margin. Positioned uniquely as an enabler in the nuclear energy sector, Mirion stands to benefit as the industry matures further. Despite concerns about rising debt amid increasing interest rates, the company appears capable of managing this challenge. Its current market valuation also presents an attractive opportunity for investors.

Mirion Technologies is noted here alongside a snapshot of the Energy sector on Pluang. For readers following energy stocks, as of Sep 23, 2026 22:03 WIB, 23 of 38 priced US energy-sector stocks rose while 14 fell. Notable movers include EQNR at USD 42.65 with a 1-day change of +2.01% and a typical hold time of 58 days, Eni SpA at USD 54.30 up 1.95% with a 50-day hold time, and Occidental Petroleum Corporation at USD 57.34 rising 1.83% with a 90-day hold time and Pluang order activity heavily skewed to buying at 98%.

More News

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
1 hour ago
BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...

Analyst Insights
Bearish
1 hour ago
Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
2 hours ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
2 hours ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App